Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.58B |
| 2 |
Netflix
NFLX
|
+$496M |
| 3 |
Meta Platforms (Facebook)
META
|
+$275M |
| 4 |
Alibaba
BABA
|
+$215M |
| 5 |
UnitedHealth
UNH
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$926M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$682M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$556M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$246M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 2.18% |
| 2 | Technology | 2.09% |
| 3 | Communication Services | 1.44% |
| 4 | Financials | 1.21% |
| 5 | Healthcare | 1.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9451
GSI Technology
GSIT
$224M
| $113K | ﹤0.01% |
12,925
-5,151
| -28% | -$43.3K |
|
|
NTRP
9452
CALL
DELISTED
Neurotrope, Inc. Common
NTRP
| $113K | ﹤0.01% |
140,000
+99,300
| +244% | +$455K |
|
|
INWK
9453
DELISTED
InnerWorkings, Inc.
INWK
| $113K | ﹤0.01% |
25,472
-14,424
| -36% | -$57.5K |
|
|
GTYH
9454
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $113K | ﹤0.01% |
17,995
-34,938
| -66% | -$226K |
|
9455
CALL
Barings BDC
BBDC
$979M
| $112K | ﹤0.01% |
11,000
-25,500
| -70% | -$253K |
|
|
PBPB
9456
PUT
DELISTED
Potbelly
PBPB
| $112K | ﹤0.01% |
25,600
+7,300
| +40% | +$32.8K |
|
|
PBT
9457
Permian Basin Royalty Trust
PBT
$1.57B
| $112K | ﹤0.01% |
+21,644
| New | +$112K |
|
9458
PUT
Expro Ltd
XPRO
$1.97B
| $112K | ﹤0.01% |
3,917
-3,950
| -50% | -$120K |
|
|
NAGE
9459
Niagen Bioscience
NAGE
$261M
| $112K | ﹤0.01% |
28,470
+6,199
| +28% | +$26.4K |
|
|
ENZ
9460
DELISTED
Enzo Biochem, Inc.
ENZ
| $112K | ﹤0.01% |
31,125
-11,913
| -28% | -$42.2K |
|
|
CALA
9461
CALL
DELISTED
Calithera Biosciences, Inc
CALA
| $112K | ﹤0.01% |
1,815
-2,040
| -53% | -$163K |
|
|
AT
9462
DELISTED
Atlantic Power Corporation
AT
| $112K | ﹤0.01% |
47,935
+2,911
| +6% | +$6.99K |
|
|
BGG
9463
PUT
DELISTED
Briggs & Stratton Corp.
BGG
| $112K | ﹤0.01% |
18,500
-43,800
| -70% | -$324K |
|
9464
PUT
ADMA Biologics
ADMA
$2.16B
| $111K | ﹤0.01% |
25,000
+1,800
| +8% | +$7.52K |
|
9465
Lipocine
LPCN
$17.7M
| $111K | ﹤0.01% |
2,328
+1,019
| +78% | +$40.9K |
|
9466
CALL
Lesaka Technologies
LSAK
$390M
| $111K | ﹤0.01% |
31,100
-1,500
| -5% | -$5.46K |
|
9467
CALL
Minerva Neurosciences
NERV
$259M
| $111K | ﹤0.01% |
1,788
+325
| +22% | +$18.4K |
|
9468
CALL
Sundial Growers
SNDL
$343M
| $111K | ﹤0.01% |
+2,310
| New | +$205K |
|
9469
Mammoth Energy Services
TUSK
$151M
| $111K | ﹤0.01% |
44,692
-26,616
| -37% | -$126K |
|
|
TGH
9470
PUT
DELISTED
Textainer Group Holdings limited
TGH
| $111K | ﹤0.01% |
11,200
-15,300
| -58% | -$141K |
|
|
IDSA
9471
DELISTED
Industrial Services of America
IDSA
| $111K | ﹤0.01% |
99,069
+82,780
| +508% | +$84.9K |
|
9472
KVH Industries
KVHI
$137M
| $110K | ﹤0.01% |
10,341
-1,208
| -10% | -$12K |
|
9473
CALL
Tilly's
TLYS
$120M
| $110K | ﹤0.01% |
11,600
-20,400
| -64% | -$180K |
|
9474
CALL
Ultralife
ULBI
$109M
| $110K | ﹤0.01% |
12,700
-36,300
| -74% | -$311K |
|
|
NPTN
9475
DELISTED
NEOPHOTONICS CORP
NPTN
| $110K | ﹤0.01% |
18,030
-174,841
| -91% | -$983K |
|
Similar funds
Jeff Yass's Q3 2019 Portfolio in Review
As of Q3 2019, Jeff Yass held 11,380 positions worth $298B, up 8.4% from $275B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass deployed $26.9B of net new capital in Q3 2019, opening 1,223 new positions and adding to 4,885 existing holdings. Its largest new stake was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 2.2% of assets, up from 1.8% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $926M trimmed.
- Jeff Yass's largest Q3 2019 buy was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.
- Jeff Yass added most to Amazon in Q3 2019, an estimated $1.58B increase.
- Jeff Yass's biggest Q3 2019 reduction was Alphabet (Google) Class A, cutting an estimated $926M.
- Jeff Yass fully exited Tableau Software, Inc. in Q3 2019, selling an estimated $179M.
- Jeff Yass's ten largest holdings make up 24% of its $298B portfolio in Q3 2019.
- Jeff Yass opened 1,223 new positions and closed 1,294 in Q3 2019.
- Jeff Yass's portfolio value rose 8.4% quarter-over-quarter to $298B.
Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.